Guide to Toremifene Citrate for PCT Side Effects,Benefits, Dosage
Tell your doctor about all your current medicines and any medicine you start or stop using. When it comes to PCT, dosages for toremifene citrate vary depending on an individual’s goals, body type, and the type of cycle they completed. Generally, a starting dose would be mg per day for 4-6 weeks.
- At Pinnacle Peptides, toremifene for sale is exclusively available for research and experimentation.
- Your doctor may test your tumor before prescribing toremifene.
- Animal doses resulting in embryo-fetal toxicities were ≥1.0 mg/kg/day in rats and ≥1.25 mg/kg/day in rabbits.
- In patients at increased risk, electrocardiograms (ECGs) should be obtained and patients monitored as clinically indicated [see BOX WARNING and WARNINGS AND PRECAUTIONS].
- Toremifene produced ovarian atrophy in dogs administered doses ≥3 mg/kg/day (approximately 1.5 times the daily maximum recommended human dose of 60 mg, on a mg/m2 basis) for 16 weeks.
Since this drug can be absorbed through the skin and lungs, women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from the tablets. Take this medication by mouth with or without food as directed by your doctor, usually once daily. The dosage is based on your medical condition and response to treatment. Toremifene citrate should only be used as part of a Post-Cycle Therapy (PCT) protocol. PCT is an essential step in any cycle of anabolic steroids or prohormones to help the body restore its natural balance of hormones after completing a cycle.
Toremifene is a first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. Similarly, androgen deprivation therapy raises serum lipid levels and increases the risk of coronary artery disease and myocardial infarction. Research conducted on men with prostate cancer undergoing antiandrogen treatment found that toremifene decreased total cholesterol, triglycerides and Enandrol Testosterona E 250 mg from Balkan Pharmaceuticals LDL-C levels [5]. Low levels of potassium or magnesium in the blood may also increase your risk of QT prolongation. This risk may increase if you use certain drugs (such as diuretics/”water pills”) or if you have conditions such as severe sweating, diarrhea, or vomiting. Although toremifene citrate is generally well tolerated, there are some potential side effects that should be taken into consideration.
Toremifene (Oral Route)
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. Talk to your care team about the use of this medication in children.
Clinical Trials
We anticipate reposting the images once we are able identify and filter out images that do not match the information provided in the drug labels. DailyMed will deliver this notification to your desktop, Web browser, or e-mail depending on the RSS Reader you select to use. To view updated drug label links, paste the RSS feed address (URL) shown below into a RSS reader, or use a browser which supports RSS feeds, such as Safari for Mac OS X. Toremifene should not be prescribed to patients with congenital/acquired QT prolongation (long QT syndrome), uncorrected hypokalemia, or uncorrected hypomagnesemia.
What happens if I miss a dose?
Improve bone mineral density and lower the risk of prostate cancer. At Pinnacle Peptides, toremifene purchase is only available for research and educational institutions. Toremifene is a medication belonging to the class of drugs known as selective estrogen receptor modulators (SERMs). It is largely employed in the management of postmenopausal women’s breast cancer.
